The Uromigos at ASCO GU 2023: miR371 for Germ Cell Tumors With Christian Kollmannsberger, MD, FRCPC

The Uromigos are joined by Christian Kollmannsberger, MD, FRCPC, to discuss his presentation at the ASCO GU Cancers Symposium on utilizing miR371 as a biomarker for germ cell tumors to help optimize patient management by improving decision-making.
Dr. Kollmannsberger is a medical oncologist at the British Columbia Cancer Agency Vancouver Cancer Centre, and Clinical Professor at the University of British Columbia.